trending Market Intelligence /marketintelligence/en/news-insights/trending/zigyz31rs2bejzilcymrnq2 content esgSubNav
In This List

Bod gets nod to ship cannabis products to Australia

Blog

Using ESG Analysis to Support a Sustainable Future

Video

S&P Capital IQ Pro | Powered by Expert Insights

Blog

Q&A: Streamlining Analytics for TCFD Reporting

Blog

Evergrande and the wider impact: a sentiment analytics based perspective


Bod gets nod to ship cannabis products to Australia

Bod Australia Ltd on Feb. 5 said it had been granted authorization to import cannabidiol powder from Linnea Natural Pharma Solutions.

The company was given permission by Australia's Office of Drug Control and will receive the shipment in mid-February.

Bod will incorporate the CBD powder into its sublingual wafer, currently under development through its partner iX Biopharma. This will take about six to eight weeks.

Bod is awaiting approval from the country's Department of Health to import Linnea's CBD oil products. Pending approval, Bod will make it available and generate revenue through a special access scheme category B, the release said.